Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.

Authors:

Klaas Van Den Heede Swathikan Chidambaram Sam Van Slycke Nele Brusselaers Carl Fredrik Warfvinge Håkan Ohlsson Erik Nordenström Martin Almquist

Br J Surg 2022 02;109(2):191-199

Department of Surgery, Skåne University Hospital, Lund, Sweden.

Background: Patients with small intestinal neuroendocrine tumours (siNETs) usually present with advanced disease. Primary tumour resection without curative intent is controversial in patients with metastatic siNETs. The aim of this meta-analysis was to investigate survival after primary tumour resection without curative intent compared with no resection in patients with metastatic siNETs.

Methods: A systematic literature search was performed, using MEDLINE® (PubMed), Embase®, Web of Science, and the Cochrane Library up to 25 February 2021. Studies were included if survival after primary tumour resection versus no resection in patients with metastatic siNETs was reported. Results were pooled in a random-effects meta-analysis, and are reported as hazard ratios (HRs) with 95 per cent confidence intervals. Sensitivity analyses were undertaken to enable comment on the impact of important confounders.

Results: After screening 3659 abstracts, 16 studies, published between 1992 and 2021, met the inclusion criteria, with a total of 9428 patients. Thirteen studies reported HRs adjusted for important confounders and were included in the meta-analysis. Median overall survival was 112 (i.q.r. 82-134) months in the primary tumour resection group compared with 60 (74-88) months in the group without resection. Five-year overall survival rates were 74 (i.q.r. 67-77) and 44 (34-45) per cent respectively. Primary tumour resection was associated with improved survival compared with no resection (HR 0.55, 95 per cent c.i. 0.47 to 0.66). This effect remained in sensitivity analyses.

Conclusion: Primary tumour resection is associated with increased survival in patients with advanced, metastatic siNETs, even after adjusting for important confounders.

Download full-text PDF	Source
http://dx.doi.org/10.1093/bjs/znab413	DOI Listing

February 2022

Publication Analysis

Top Keywords

neuroendocrine tumours

meta-analysis reported

criteria total

Keyword Occurance

Similar Publications

Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy.

Authors:

Dagmara Grot Katarzyna Wasiak Jerzy Tyszkowski Ewelina Stoczynska-Fidelus Tomasz P Ochedalski Piotr Rieske

Stem Cell Res Ther 2022 May 21;13(1):210. Epub 2022 May 21.

Department of Tumor Biology, Medical University of Lodz, Zeligowskiego 7/9, 90-752, Lodz, Poland.

Etiopathogenesis of fluoroquinolone-associated disability (FQAD) syndrome is not fully understood, yet research could progress by utilizing induced pluripotent stem cells (iPSc) from people with this syndrome. Similarly, iPSc, or rather their derivatives, could be used in their therapy, not only for FQAD but also for other disorders in which generated autologous iPSc and their derivatives might be helpful. Urine was collected from ten donors with FQAD, and reprogramming of these cells was conducted with the use of Epi5TM Episomal iPSC Reprogramming Kit. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types.

Authors:

G Maria Jakobsdottir Daniel S Brewer Colin Cooper Catherine Green David C Wedge

BMC Biol 2022 May 21;20(1):117. Epub 2022 May 21.

Big Data Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.

Background: The APOBEC3 (apolipoprotein B mRNA editing enzyme catalytic polypeptide 3) family of cytidine deaminases is responsible for two mutational signatures (SBS2 and SBS13) found in cancer genomes. APOBEC3 enzymes are activated in response to viral infection, and have been associated with increased mutation burden and TP53 mutation. In addition to this, it has been suggested that APOBEC3 activity may be responsible for mutations that do not fall into the classical APOBEC3 signatures (SBS2 and SBS13), through generation of double strand breaks. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

Introduction of salvage prostatectomy in Denmark: the initial experience.

Authors:

Mike Allan Mortensen Charlotte Aaberg Poulsen Göran Ahlgren Kirsten Madsen Mads Hvid Poulsen

BMC Res Notes 2022 May 21;15(1):185. Epub 2022 May 21.

Department of Urology, Odense University Hospital, Odense, Denmark.

Objective: To introduce salvage prostatectomy in Denmark. Prior to this, no national curative treatment for recurrent prostate cancer following radiation therapy existed in Denmark. This pilot study represent our initial experiences and the feasibility of performing salvage robot-assisted radical prostatectomy for true local, high-risk recurrence after initial therapy with external beam radiation for high-risk prostate cancer. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer.

Authors:

Gowoon Yang Jee Suk Chang Jeong Eun Choi Eun Sil Baek Seung-Seob Kim Hwa Kyung Byun Yeona Cho Woong Sub Koom Seung Yoon Yang Byung Soh Min Sang Joon Shin

Radiat Oncol 2022 May 21;17(1):100. Epub 2022 May 21.

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

Background: We investigated the prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) in patients with locally advanced rectal cancer (LARC) and whether modifiable factors in radiotherapy (RT) influenced the NLR.

Methods: Data of 1386 patients who were treated with neoadjuvant RT and concurrent or sequential chemotherapy for LARC between 2006 and 2019 were evaluated. Most patients (97. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

Biliary obstruction and pancreatitis after duodenal stent placement in the descending duodenum: a retrospective study.

Authors:

Junichi Kaneko Hirotoshi Ishiwatari Koiku Asakura Tatsunori Satoh Junya Sato Kazuma Ishikawa Hiroyuki Matsubayashi Yohei Yabuuchi Yoshihiro Kishida Masao Yoshida Sayo Ito Noboru Kawata Kenichiro Imai Kohei Takizawa Kinichi Hotta Hiroyuki Ono

BMC Gastroenterol 2022 May 21;22(1):257. Epub 2022 May 21.

Division of Endoscopy, Shizuoka Cancer Center, 1007 Shimonagakubo Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Background: Metallic stents placed in the descending duodenum can cause compression of the major duodenal papilla, resulting in biliary obstruction and pancreatitis. These are notable early adverse events of duodenal stent placement; however, they have been rarely examined. This study aimed to assess the incidence of and risk factors for biliary obstruction and/or pancreatitis after duodenal stent placement in the descending duodenum. Read More

View Article and Full-Text PDF

May 2022

Similar Publications

}

Search Our Scientific Publications & Authors